Matthias Bernard Donelan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 32 | 2024 | 1882 | 4.470 |
Why?
|
| Cicatrix, Hypertrophic | 9 | 2021 | 81 | 2.800 |
Why?
|
| Skin Transplantation | 12 | 2024 | 1083 | 2.240 |
Why?
|
| Hand Injuries | 4 | 2021 | 239 | 1.360 |
Why?
|
| Lip | 3 | 2020 | 197 | 1.250 |
Why?
|
| Contracture | 5 | 2024 | 235 | 1.150 |
Why?
|
| Cicatrix | 11 | 2024 | 798 | 1.130 |
Why?
|
| Lasers, Gas | 4 | 2021 | 101 | 1.040 |
Why?
|
| Laser Therapy | 9 | 2024 | 1092 | 1.000 |
Why?
|
| Tissue Expansion | 4 | 2010 | 160 | 0.940 |
Why?
|
| Lasers, Dye | 4 | 2017 | 28 | 0.830 |
Why?
|
| Ear, External | 2 | 2020 | 165 | 0.730 |
Why?
|
| Surgical Flaps | 10 | 2024 | 1671 | 0.660 |
Why?
|
| Facial Injuries | 3 | 2010 | 190 | 0.660 |
Why?
|
| Wrist Injuries | 1 | 2021 | 214 | 0.640 |
Why?
|
| Scalp | 3 | 2010 | 389 | 0.560 |
Why?
|
| Anal Canal | 1 | 2018 | 373 | 0.490 |
Why?
|
| Burns, Electric | 2 | 2009 | 40 | 0.440 |
Why?
|
| Epithelium | 1 | 2018 | 1603 | 0.430 |
Why?
|
| Suture Techniques | 2 | 2007 | 769 | 0.390 |
Why?
|
| Forehead | 1 | 2010 | 75 | 0.340 |
Why?
|
| Skull | 2 | 2009 | 818 | 0.340 |
Why?
|
| Lipodystrophy | 1 | 2006 | 145 | 0.250 |
Why?
|
| Rhinoplasty | 1 | 2009 | 238 | 0.250 |
Why?
|
| Wound Healing | 8 | 2021 | 2805 | 0.250 |
Why?
|
| Esthetics | 3 | 2020 | 330 | 0.240 |
Why?
|
| Skin Pigmentation | 2 | 2021 | 277 | 0.240 |
Why?
|
| Finger Injuries | 1 | 2006 | 145 | 0.240 |
Why?
|
| Nails | 1 | 2006 | 296 | 0.230 |
Why?
|
| Bandages | 2 | 2023 | 269 | 0.220 |
Why?
|
| Surgery, Plastic | 2 | 2010 | 643 | 0.220 |
Why?
|
| Hand Deformities, Acquired | 2 | 2017 | 36 | 0.210 |
Why?
|
| Fluid Therapy | 3 | 2023 | 579 | 0.210 |
Why?
|
| Face | 1 | 2008 | 1026 | 0.200 |
Why?
|
| Ear Cartilage | 2 | 2020 | 62 | 0.190 |
Why?
|
| Postoperative Care | 3 | 2017 | 1468 | 0.180 |
Why?
|
| Adolescent | 20 | 2021 | 88326 | 0.180 |
Why?
|
| Erythema | 1 | 2021 | 262 | 0.170 |
Why?
|
| Elasticity | 1 | 2021 | 655 | 0.170 |
Why?
|
| Skin | 6 | 2020 | 4484 | 0.150 |
Why?
|
| Humans | 44 | 2024 | 761596 | 0.140 |
Why?
|
| Infection Control | 1 | 2023 | 982 | 0.130 |
Why?
|
| Acne Vulgaris | 1 | 2021 | 358 | 0.130 |
Why?
|
| Morbidity | 1 | 2021 | 1752 | 0.130 |
Why?
|
| Child | 17 | 2021 | 80158 | 0.120 |
Why?
|
| Injury Severity Score | 4 | 2009 | 1045 | 0.100 |
Why?
|
| Mouth | 1 | 1995 | 381 | 0.100 |
Why?
|
| Recovery of Function | 2 | 2020 | 2979 | 0.100 |
Why?
|
| Quality of Life | 4 | 2021 | 13367 | 0.100 |
Why?
|
| Cosmetic Techniques | 1 | 2014 | 149 | 0.100 |
Why?
|
| Male | 24 | 2021 | 360846 | 0.090 |
Why?
|
| Female | 24 | 2021 | 392705 | 0.090 |
Why?
|
| Toll-Like Receptors | 1 | 2014 | 589 | 0.090 |
Why?
|
| Lipectomy | 1 | 1992 | 113 | 0.090 |
Why?
|
| Interferons | 1 | 2014 | 706 | 0.090 |
Why?
|
| Dermatology | 1 | 2020 | 918 | 0.090 |
Why?
|
| Eyebrows | 1 | 2010 | 37 | 0.080 |
Why?
|
| Ear Deformities, Acquired | 1 | 1989 | 2 | 0.080 |
Why?
|
| Treatment Outcome | 7 | 2021 | 64685 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2014 | 727 | 0.080 |
Why?
|
| Phrenic Nerve | 1 | 2009 | 79 | 0.080 |
Why?
|
| Child, Preschool | 12 | 2009 | 42232 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2021 | 5971 | 0.080 |
Why?
|
| Adult | 14 | 2021 | 221210 | 0.070 |
Why?
|
| Skin Physiological Phenomena | 1 | 1988 | 188 | 0.070 |
Why?
|
| Fibrosis | 1 | 2014 | 2049 | 0.070 |
Why?
|
| Retrospective Studies | 7 | 2020 | 80647 | 0.070 |
Why?
|
| Scalp Dermatoses | 1 | 2007 | 44 | 0.070 |
Why?
|
| Sensation | 2 | 1988 | 337 | 0.070 |
Why?
|
| Pain | 1 | 2021 | 5073 | 0.060 |
Why?
|
| Alopecia | 1 | 2010 | 412 | 0.060 |
Why?
|
| Facial Paralysis | 1 | 2009 | 346 | 0.060 |
Why?
|
| Hamartoma | 1 | 2007 | 235 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2014 | 4142 | 0.060 |
Why?
|
| Debridement | 2 | 2013 | 493 | 0.050 |
Why?
|
| Collagen | 2 | 2009 | 2638 | 0.050 |
Why?
|
| Radiographic Magnification | 1 | 1979 | 19 | 0.040 |
Why?
|
| Proteoglycans | 2 | 1993 | 803 | 0.040 |
Why?
|
| Cytokines | 1 | 2014 | 7396 | 0.040 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2002 | 246 | 0.040 |
Why?
|
| Soft Tissue Injuries | 1 | 2020 | 172 | 0.040 |
Why?
|
| Consensus | 2 | 2021 | 3124 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 54423 | 0.040 |
Why?
|
| Middle Aged | 6 | 2021 | 220921 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 59260 | 0.040 |
Why?
|
| Reoperation | 1 | 2007 | 4303 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 621 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 1988 | 3313 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2019 | 846 | 0.030 |
Why?
|
| Epidermis | 1 | 1998 | 528 | 0.030 |
Why?
|
| Infant | 5 | 2009 | 36193 | 0.030 |
Why?
|
| Antimetabolites | 1 | 2016 | 129 | 0.030 |
Why?
|
| Military Medicine | 1 | 2017 | 184 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2016 | 280 | 0.030 |
Why?
|
| Pediatrics | 1 | 2010 | 3589 | 0.030 |
Why?
|
| Transplantation, Autologous | 2 | 2016 | 2115 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 8527 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 4948 | 0.030 |
Why?
|
| Time Factors | 3 | 2014 | 39969 | 0.030 |
Why?
|
| Angiography | 1 | 1979 | 1595 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2009 | 9319 | 0.030 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2013 | 28 | 0.030 |
Why?
|
| Oxandrolone | 1 | 2013 | 24 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2010 | 39106 | 0.030 |
Why?
|
| Complement Pathway, Alternative | 2 | 1983 | 113 | 0.030 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 393 | 0.030 |
Why?
|
| Occupational Therapy | 1 | 2013 | 139 | 0.020 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1992 | 130 | 0.020 |
Why?
|
| Nutritional Requirements | 1 | 2013 | 276 | 0.020 |
Why?
|
| Complement Activation | 2 | 1983 | 445 | 0.020 |
Why?
|
| Wound Infection | 1 | 2013 | 246 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2016 | 1642 | 0.020 |
Why?
|
| Multiple Organ Failure | 1 | 2013 | 387 | 0.020 |
Why?
|
| Anabolic Agents | 1 | 2013 | 256 | 0.020 |
Why?
|
| Preoperative Care | 1 | 1979 | 2242 | 0.020 |
Why?
|
| Glutamine | 1 | 2013 | 577 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7391 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2013 | 809 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 1993 | 1248 | 0.020 |
Why?
|
| Physical Therapy Modalities | 1 | 2013 | 532 | 0.020 |
Why?
|
| Ear | 1 | 2010 | 172 | 0.020 |
Why?
|
| Anesthesia, Spinal | 1 | 1992 | 280 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2013 | 617 | 0.020 |
Why?
|
| Smiling | 1 | 2009 | 72 | 0.020 |
Why?
|
| Methods | 1 | 1989 | 1067 | 0.020 |
Why?
|
| Resuscitation | 1 | 2013 | 673 | 0.020 |
Why?
|
| Facial Muscles | 1 | 2009 | 159 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 1992 | 638 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2013 | 952 | 0.020 |
Why?
|
| Eyelids | 1 | 2010 | 278 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2013 | 667 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2013 | 1241 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2013 | 947 | 0.020 |
Why?
|
| Suction | 1 | 1988 | 266 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 1881 | 0.020 |
Why?
|
| Nose | 1 | 2010 | 521 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 1809 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1403 | 0.020 |
Why?
|
| Energy Intake | 1 | 2013 | 2134 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 1992 | 1174 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2013 | 1615 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2013 | 1376 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2009 | 1201 | 0.010 |
Why?
|
| Schools | 1 | 2013 | 1489 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 10212 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2013 | 6019 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 7406 | 0.010 |
Why?
|
| Survivors | 1 | 2013 | 2371 | 0.010 |
Why?
|
| Thumb | 1 | 1984 | 232 | 0.010 |
Why?
|
| Nails, Malformed | 1 | 2002 | 34 | 0.010 |
Why?
|
| Weight Loss | 1 | 2013 | 2684 | 0.010 |
Why?
|
| Burn Units | 1 | 2002 | 143 | 0.010 |
Why?
|
| Fingers | 1 | 1984 | 507 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2013 | 3905 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2013 | 3415 | 0.010 |
Why?
|
| Prognosis | 2 | 1998 | 29629 | 0.010 |
Why?
|
| Toes | 1 | 1979 | 209 | 0.010 |
Why?
|
| Graft Survival | 2 | 1998 | 3820 | 0.010 |
Why?
|
| Pain Measurement | 1 | 1988 | 3551 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1988 | 1667 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 8833 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 3462 | 0.010 |
Why?
|
| Purpura | 1 | 1997 | 117 | 0.010 |
Why?
|
| Eye Diseases | 1 | 2002 | 653 | 0.010 |
Why?
|
| Length of Stay | 2 | 2002 | 6426 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2013 | 4575 | 0.010 |
Why?
|
| Pilot Projects | 2 | 1998 | 8633 | 0.010 |
Why?
|
| Body Mass Index | 1 | 1992 | 12953 | 0.010 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1993 | 16 | 0.010 |
Why?
|
| Depression | 1 | 2013 | 8126 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18399 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2002 | 1094 | 0.010 |
Why?
|
| Necrosis | 1 | 1997 | 1611 | 0.010 |
Why?
|
| Chromatography | 1 | 1991 | 189 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 21355 | 0.010 |
Why?
|
| Extremities | 1 | 1997 | 867 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1993 | 795 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 1998 | 1668 | 0.010 |
Why?
|
| Sulfates | 1 | 1991 | 380 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1998 | 4807 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1991 | 561 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 10090 | 0.010 |
Why?
|
| Boston | 1 | 2002 | 9327 | 0.000 |
Why?
|
| Aged | 3 | 1992 | 169310 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1999 | 1924 | 0.000 |
Why?
|
| Comorbidity | 1 | 2002 | 10508 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1988 | 15633 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1993 | 6534 | 0.000 |
Why?
|
| Zymosan | 1 | 1983 | 134 | 0.000 |
Why?
|
| Complement Pathway, Classical | 1 | 1982 | 91 | 0.000 |
Why?
|
| Risk Factors | 1 | 2010 | 74213 | 0.000 |
Why?
|
| Complement C4 | 1 | 1983 | 217 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1984 | 1625 | 0.000 |
Why?
|
| Complement C3 | 1 | 1983 | 435 | 0.000 |
Why?
|
| Bone Transplantation | 1 | 1984 | 929 | 0.000 |
Why?
|
| Movement | 1 | 1984 | 1478 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1991 | 18966 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 1997 | 26129 | 0.000 |
Why?
|
| Pneumonia | 1 | 1983 | 2143 | 0.000 |
Why?
|
| Neutrophils | 1 | 1982 | 3767 | 0.000 |
Why?
|
| Mice | 2 | 1983 | 81539 | 0.000 |
Why?
|
| Lung | 1 | 1982 | 10002 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1982 | 18255 | 0.000 |
Why?
|
| Animals | 2 | 1983 | 168475 | 0.000 |
Why?
|